Sebelipase Alfa
| Use attributes for filter ! | |
| Trade name | Kanuma |
|---|---|
| ATC code | A16AB14 (WHO) |
| Elimination half-life | 0. 1 hours |
| Date of Reg. | |
| Date of Upd. | |
| ID | 962009 |
About Sebelipase Alfa
Sebelipase alfa is a recombinant form of the enzyme lysosomal acid lipase that was approved in 2015 under the tradename Kanuma in the US and EU for the treatment of people with lysosomal acid lipase deficiency. Sebelipase was developed by Synageva that became part of Alexion Pharmaceuticals in 2015.
